PHS
QURE icon

PFM Health Sciences’s uniQure QURE Stock Holding History

PFM Health Sciences’s Portfolio QURE Stock Details QURE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22M Sell
26,396
-16,239
-38% -$425K 0.1% 96
2026
Q1 		$697K Buy
42,635
+3,136
+8% +$63.5K 0.06% 82
2025
Q4 		$945K Sell
39,499
-6,854
-15% -$264K 0.09% 73
2025
Q3 		$2.71M Sell
46,353
-127,978
-73% -$2.32M 0.21% 64
2025
Q2 		$2.43M Sell
174,331
-425,636
-71% -$5.73M 0.21% 48
2025
Q1 		$6.36M Buy
599,967
+316,809
+112% +$4.44M 0.46% 39
2024
Q4 		$5M Buy
283,158
+161,530
+133% +$1.39M 0.31% 55
2024
Q3 		$600K Sell
121,628
-152,912
-56% -$996K 0.03% 74
2024
Q2 		$1.23M Hold
274,540
– – 0.06% 73
2024
Q1 		$1.43M Buy
+274,540
New +$1.58M 0.07% 86
2023
Q3 		– Sell
-60,617
Closed -$695K – 83
2023
Q2 		$695K Sell
60,617
-2,049,453
-97% -$38.8M 0.03% 82
2023
Q1 		$42.5M Sell
2,110,070
-192,244
-8% -$4.03M 1.88% 19
2022
Q4 		$52.2M Sell
2,302,314
-90,997
-4% -$1.96M 1.87% 16
2022
Q3 		$44.9M Buy
2,393,311
+156,941
+7% +$3.3M 1.62% 23
2022
Q2 		$41.7M Buy
2,236,370
+1,701,746
+318% +$27.1M 1.59% 21
2022
Q1 		$9.66M Buy
+534,624
New +$9.34M 0.36% 54
2019
Q4 		– Sell
-1,158,694
Closed -$45.6M – 74
2019
Q3 		$45.6M Buy
1,158,694
+983,940
+563% +$56.8M 1.35% 31
2019
Q2 		$13.7M Sell
174,754
-242,108
-58% -$15.4M 0.26% 75
2019
Q1 		$24.9M Buy
+416,862
New +$18.6M 0.55% 60

Other funds holding QURE

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

PFM Health Sciences's QURE Position: Q2 2026 in Review

PFM Health Sciences reduced its uniQure (QURE) stake by 38% in Q2 2026, selling an estimated $425K and leaving 26,396 shares worth $1.22M. The position accounts for 0.1% of the portfolio, ranked #96.

PFM Health Sciences first reported a position in QURE in Q1 2019 and has held it in 19 quarters since. The position peaked at $52.2M in Q4 2022. 254 funds tracked by Wall St. Rank hold QURE as of Q2 2026.

  • PFM Health Sciences held 26,396 shares of uniQure worth $1.22M as of Q2 2026.
  • PFM Health Sciences sold 16,239 uniQure shares in Q2 2026, an estimated $425K.
  • uniQure made up 0.1% of PFM Health Sciences's portfolio in Q2 2026, its #96 holding.
  • PFM Health Sciences first reported a position in uniQure in Q1 2019 and has held it in 19 quarters since.
  • PFM Health Sciences's uniQure position peaked at $52.2M in Q4 2022.
  • 254 funds tracked by Wall St. Rank held uniQure as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.